Inogen | INGN - Sales Revenues


Inogen reported $74.93M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Chart Industries USD 1.08B 20M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Philips EUR 5.1B 797M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
X T L Biopharmaceuticals USD 289K 127K Dec/2024
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025